CEDAX Drug Patent Profile
✉ Email this page to a colleague
When do Cedax patents expire, and what generic alternatives are available?
Cedax is a drug marketed by Si Pharms and is included in two NDAs.
The generic ingredient in CEDAX is ceftibuten dihydrate. Additional details are available on the ceftibuten dihydrate profile page.
Summary for CEDAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Patent Applications: | 4,636 |
What excipients (inactive ingredients) are in CEDAX? | CEDAX excipients list |
DailyMed Link: | CEDAX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CEDAX
US Patents and Regulatory Information for CEDAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Si Pharms | CEDAX | ceftibuten dihydrate | CAPSULE;ORAL | 050685-002 | Dec 20, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Si Pharms | CEDAX | ceftibuten dihydrate | FOR SUSPENSION;ORAL | 050686-001 | Dec 20, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Si Pharms | CEDAX | ceftibuten dihydrate | FOR SUSPENSION;ORAL | 050686-002 | Dec 20, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CEDAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Si Pharms | CEDAX | ceftibuten dihydrate | FOR SUSPENSION;ORAL | 050686-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Si Pharms | CEDAX | ceftibuten dihydrate | FOR SUSPENSION;ORAL | 050686-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Si Pharms | CEDAX | ceftibuten dihydrate | CAPSULE;ORAL | 050685-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CEDAX
See the table below for patents covering CEDAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S60163884 | CARBOXYALKENAMIDOCEPHALOSPORIN | ⤷ Try a Trial |
United Kingdom | 8700123 | ⤷ Try a Trial | |
Finland | 945081 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CEDAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0136721 | 95C0002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CEFTIBUTEN + SURDOSAGE DE 8% ; NAT REG.: 304 S 146 FO 19941222; FIRST REG.: IT 0 27 84 9052 19920303 |
0136721 | 95C0003 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CEFTIBUTEN.; NAT REG.: 304 S 144 F5 19941222; FIRST REG.: IT 0 27 84 9025 19920303 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |